Lactobacillus crispatus CTV-05
Selected indexed studies
- Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial. (Lancet Microbe, 2025) [PMID:40194532]
- Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease. (Sex Transm Dis, 2024) [PMID:38733973]
- Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. (N Engl J Med, 2020) [PMID:32402161]
_Worker-drafted node — pending editorial review._
Connections
Lactobacillus crispatus CTV-05 helps
Sources
- Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. (2020) pubmed
- Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial. (2025) pubmed
- Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease. (2024) pubmed
- The endometrial microbiota and early pregnancy loss. (2024) pubmed
- Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05. (2027) pubmed
- Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. (2009) pubmed
- Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth. (2023) pubmed
- Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial. (2025) pubmed
- Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial. (2022) pubmed
- DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. (2003) pubmed